Congress Passes Three Month Budget Continuation – Marijuana Protections Included

Generic 11 September 2017 | 0 Comments

In a quick deal between President Trump and Congress, a three-month budget continuing resolution will be in effect until December 8, 2017, maintaining current spending levels. While this seems mundane (it is), it is important for marijuana policy because it guarantees a temporary extension of the Rohrabacher-Blumenauer protections for lawful medical marijuana programs from Attorney [...]

Tagged in , , ,

House Rules Committee Blocks Marijuana Amendments

Generic 8 September 2017 | 0 Comments

Late Wednesday night, the House Rules Committee led by prohibitionist Representative Pete Sessions (R-TX) blocked multiple amendments related to marijuana from receiving consideration by the full House, thus ending their consideration and silencing the ability for the lower chamber to offer protections from Attorney General Jeff Sessions when it comes to cannabis. Amendments included: ending the [...]

Tagged in , , ,

Medical Marijuana Protections Offered Again, But Will They Receive A Vote?

Generic 25 August 2017 | 0 Comments

This week, Representatives Dana Rohrabacher, Earl Blumenauer, and allies in the House of Representatives have again offered the Rohrabacher-Blumenauer amendment to protect lawful state medical marijuana programs from the federal government. Specifically, it would limit the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers. Although the amendment was reauthorized by Congress [...]

Tagged in , , ,

Senate Committee Passes Amendment To Protect Medical Marijuana

Generic 28 July 2017 | 0 Comments

Senator Patrick Leahy Today, Senator Patrick Leahy (D-VT) successfully offered and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee to protect lawful medical marijuana programs from the Department of Justice. Initially enacted by Congress in 2014, the amendment maintains that federal funds cannot be used to prevent states from “implementing their own state laws that [...]

Tagged in , , ,

First Meeting Of Trump’s Opioid Commission: Will It Be Effective?

Generic 16 June 2017 | 0 Comments

Today, the Office of National Drug Control Policy convened it’s first meeting of President Trump’s “Commission on Combating Drug Addiction and the Opioid Crisis.” The Commission is tasked with making recommendations for improving the Federal response to opioid misuse and abuse. Best evidence informs us that medical marijuana access is associated with reduced levels of opioid-related [...]

Tagged in